Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Hypothalamic obesity in children.

Bereket A, Kiess W, Lustig RH, Muller HL, Goldstone AP, Weiss R, Yavuz Y, Hochberg Z.

Obes Rev. 2012 Sep;13(9):780-98. doi: 10.1111/j.1467-789X.2012.01004.x. Review.

PMID:
22577758
2.

Hypothalamic obesity in humans: what do we know and what can be done?

Pinkney J, Wilding J, Williams G, MacFarlane I.

Obes Rev. 2002 Feb;3(1):27-34. Review.

PMID:
12119657
3.

Hypothalamic obesity.

Hochberg I, Hochberg Z.

Endocr Dev. 2010;17:185-96. doi: 10.1159/000262539. Review.

PMID:
19955767
4.

Expanding the definition of hypothalamic obesity.

Hochberg I, Hochberg Z.

Obes Rev. 2010 Oct;11(10):709-21. doi: 10.1111/j.1467-789X.2010.00727.x. Review.

PMID:
20233310
5.

A novel rodent model that mimics the metabolic sequelae of obese craniopharyngioma patients.

Roth CL, Blevins JE, Ralston M, Elfers C, Ogimoto K, Kaiyala KJ, Morton GJ.

Pediatr Res. 2011 Mar;69(3):230-6. doi: 10.1203/PDR.0b013e3182083b67.

6.

Dexamphetamine use for management of obesity and hypersomnolence following hypothalamic injury.

Ismail D, O'Connell MA, Zacharin MR.

J Pediatr Endocrinol Metab. 2006 Feb;19(2):129-34.

PMID:
16562585
7.

Weight gain in craniopharyngioma--a model for hypothalamic obesity.

Ahmet A, Blaser S, Stephens D, Guger S, Rutkas JT, Hamilton J.

J Pediatr Endocrinol Metab. 2006 Feb;19(2):121-7.

PMID:
16562584
8.

Craniopharyngioma and hypothalamic obesity in children.

Vinchon M, Weill J, Delestret I, Dhellemmes P.

Childs Nerv Syst. 2009 Mar;25(3):347-52. doi: 10.1007/s00381-008-0754-x.

PMID:
19057910
9.

Review of physiology, clinical manifestations, and management of hypothalamic obesity in humans.

Lee M, Korner J.

Pituitary. 2009;12(2):87-95. doi: 10.1007/s11102-008-0096-4. Review.

PMID:
18327643
10.

Syndromes of hypothalamic obesity in man.

Bray GA.

Pediatr Ann. 1984 Jul;13(7):525-36. Review. No abstract available.

PMID:
6382132
11.

Tumor origin and growth pattern at diagnosis and surgical hypothalamic damage predict obesity in pediatric craniopharyngioma.

Park SW, Jung HW, Lee YA, Shin CH, Yang SW, Cheon JE, Kim IO, Phi JH, Kim SK, Wang KC.

J Neurooncol. 2013 Jul;113(3):417-24. doi: 10.1007/s11060-013-1128-0.

12.

Functional capacity, obesity and hypothalamic involvement: cross-sectional study on 212 patients with childhood craniopharyngioma.

Müller HL, Faldum A, Etavard-Gorris N, Gebhardt U, Oeverink R, Kolb R, Sörensen N.

Klin Padiatr. 2003 Nov-Dec;215(6):310-4.

PMID:
14677094
13.

Hypothalamic obesity.

Babcock Gilbert S, Roth LW.

Minerva Endocrinol. 2015 Mar;40(1):61-70. Review.

PMID:
25370939
14.

Hypothalamic obesity in a patient with craniopharyngioma: dysregulation of neurohormonal control of energy balance.

Maniatis AK, Simmons JH, Zeitler PS.

Curr Opin Pediatr. 2005 Apr;17(2):275-9. No abstract available.

PMID:
15800425
15.

The role of the autonomic nervous system in hypothalamic feeding syndromes.

Grijalva CV, Lindholm E.

Appetite. 1982 Jun;3(2):111-24. Review. No abstract available.

PMID:
6753741
16.

Endocrine and neuroanatomic features associated with weight gain and obesity in adult patients with hypothalamic damage.

Daousi C, Dunn AJ, Foy PM, MacFarlane IA, Pinkney JH.

Am J Med. 2005 Jan;118(1):45-50.

PMID:
15639209
17.

Growth in children with a craniopharyngioma.

Blethen SL.

Pediatrician. 1987;14(4):242-5. Review.

PMID:
2840646
18.

Effects of T3 treatment on brown adipose tissue and energy expenditure in a patient with craniopharyngioma and hypothalamic obesity.

van Santen HM, Schouten-Meeteren AY, Serlie M, Meijneke RW, van Trotsenburg AS, Verberne H, Holleman F, Fliers E.

J Pediatr Endocrinol Metab. 2015 Jan;28(1-2):53-7. doi: 10.1515/jpem-2014-0337.

PMID:
25514327
19.

[Childhood craniopharyngioma with hypothalamic obesity - no long-term weight reduction due to rehabilitation programs].

Sterkenburg AS, Hoffmann A, Gebhardt U, Waldeck E, Springer S, Müller HL.

Klin Padiatr. 2014 Nov;226(6-7):344-50. doi: 10.1055/s-0034-1387747. German.

PMID:
25431867
20.

Use of somatostatin analogues in obesity.

Tzotzas T, Papazisis K, Perros P, Krassas GE.

Drugs. 2008;68(14):1963-73. Review.

PMID:
18778119

Supplemental Content

Support Center